Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor–Interacting Protein–mutated Pediatric Somatotropinoma

Complicated Clinical Course in Incipient Gigantism Due to Treatment-resistant Aryl Hydrocarbon Receptor–Interacting Protein–mutated Pediatric Somatotropinoma

Background: Our objective was to describe the clinical course and treatment challenges in a very young patient with a pituitary adenoma due to a novel aryl hydrocarbon receptor–interacting protein (AIP) gene mutation, highlighting the limitations of somatostatin receptor immunohistochemistry to pred...

Full description

Bibliographic Details
Main Authors: Selveta Sanne van Santen, MD, MSc, Adrian F. Daly, MB, BCh, PhD, Michael Buchfelder, MD, PhD, Roland Coras, MD, Yining Zhao, MD, MSc, Albert Beckers, MD, PhD, Aart Jan van der Lely, MD, PhD, Leo J. Hofland, MD, PhD, Rutger K. Balvers, MD, PhD, P. van Koetsveld, Ing, Marry Marrigje van den Heuvel-Eibrink, MD, PhD, Sebastian Johannes Cornelis Martinus Maria Neggers, MD, PhD
Format: Article
Language:English
Published: Elsevier 2022-05-01
Series:AACE Clinical Case Reports
Subjects:
acromegaly
gigantism
AIP mutation
pituitary adenoma
macroadenoma
somatotropinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060521001279

Internet

http://www.sciencedirect.com/science/article/pii/S2376060521001279

Similar Items